title: L-ascorbic acid amplification of bladder carcinogenesis promotion by K2CO3.
abstract: The dose dependence of K2CO3 promotion of two-stage urinary bladder carcinogenesis and the amplifying effects of additional L-ascorbic acid (AsA) administration were investigated. Male F344 rats were given 0.05% N-butyl-N-(4-hydroxybutyl)nitrosamine in their drinking water for 4 weeks and then fed basal diet containing K2CO3 at levels of 0, 1, 1.5, 2.2, and 3% with or without 5% AsA or 3% NaHCO3 supplementation from weeks 5 to 8 (4 weeks) and weeks 12 to 20 (9 weeks). During weeks 9 to 11 (3 weeks), the rats were fed 3% uracil in their diet. For controls, rats without N-butyl-N-(4-hydroxybutyl)nitrosamine treatment were given either 3% K2CO3, 5% AsA, or both plus the uracil treatment. The total observation period was 20 weeks. K2CO3 dose dependently increased the numbers of the putative preneoplastic lesion, papillary or nodular hyperplasia, and papillomas in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine. AsA (5%), while itself exerting no promoting effect, amplified the enhancing influence of K2CO3 on the induction of papillary or nodular hyperplasia and papillomas. The dose-dependent elevation of urinary pH and K+ concentration was associated with K2CO3 treatment with or without AsA. Thus, increased urinary pH and K+ concentration appear to play important roles in K2CO3 promotion, and AsA amplifies this promotion.
authors.affiliation: First Department of Pathology, Nagoya City University Medical School, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Fukushima
authors.forename: Y
authors.initials: Y
authors.lastname: Kurata
authors.forename: R
authors.initials: R
authors.lastname: Hasegawa
authors.forename: M
authors.initials: M
authors.lastname: Asamoto
authors.forename: M A
authors.initials: MA
authors.lastname: Shibata
authors.forename: S
authors.initials: S
authors.lastname: Tamano
mesh_terms: D000818:Animals; D001205:Ascorbic Acid / Q000633:toxicity*; D001835:Body Weight / Q000187:drug effects; D002254:Carbonates / Q000633:toxicity*; D002277:Carcinoma / Q000139:chemically induced / Q000473:pathology; D004357:Drug Synergism; D006965:Hyperplasia; D008297:Male; D009929:Organ Size / Q000187:drug effects; D010212:Papilloma / Q000139:chemically induced / Q000473:pathology; D011188:Potassium / Q000633:toxicity*; D051381:Rats; D011916:Rats, Inbred F344; D012016:Reference Values; D001743:Urinary Bladder / Q000187:drug effects / Q000473:pathology*; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced* / Q000473:pathology
chemical_list: D002254:Carbonates; C037593:potassium carbonate; D001205:Ascorbic Acid; D011188:Potassium